TCTN1 Induces Fatty Acid Oxidation to Promote Melanoma Metastasis
Metabolic reprogramming promotes and sustains multiple steps of melanoma metastasis. Identification of key regulators of metabolic reprogramming could lead to the development of treatments for preventing and treating metastatic melanoma. In this study, we identified that tectonic family member 1 (TCTN1) promotes melanoma metastasis by increasing fatty acid oxidation (FAO). In clinical melanoma samples, high expression of TCTN1 correlated with increased metastasis and shorter patient survival. Functionally, TCTN1 promoted melanoma invasion and migration in vitro and distant metastasis in vivo and induced a mesenchymal-like phenotype switch. Mechanistically, TCTN1 acted as a protein scaffold to promote the binding of HADHA and HADHB, subunits of the mitochondrial trifunctional protein complex, thus leading to FAO activation. TCTN1-mediated FAO activated the p38/MAPK signaling pathway in melanoma cells, promoting tumor epithelial-mesenchymal transition and stemness. Molecular docking indicated that the prostaglandin F receptor agonist fluprostenol can block HADHA/HADHB binding, which was confirmed experimentally. Treatment with fluprostenol was able to inhibit TCTN1-induced melanoma invasion and metastasis. Taken together, these findings elucidate the mechanism of TCTN1-mediated promotion of melanoma metastasis and support the potential application of fluprostenol for targeted therapy of metastatic melanoma. Significance: TCTN1 activates fatty acid oxidation to induce melanoma mesenchymal phenotype switching and invasion by promoting the binding of the subunits of MTP, which can be targeted with fluprostenol to inhibit melanoma metastasis.
Authors
- Zucheng Luo (ORCID: https://orcid.org/0000-0002-0883-6369)
- Yinlam Li (ORCID: https://orcid.org/0000-0001-9667-113X)
- Kangjie Shen (ORCID: https://orcid.org/0000-0002-3144-3758)
- Jianrui Li
- Yiteng Ding
- Yang Yang (ORCID: https://orcid.org/0000-0001-7710-0331)
- Shaoluan Zheng (ORCID: https://orcid.org/0000-0002-1824-771X)
- Chuanyuan Wei (ORCID: https://orcid.org/0000-0001-5580-6499)
- Jiangying Xuan (ORCID: https://orcid.org/0000-0001-9599-181X)
- Ren Ming (ORCID: https://orcid.org/0009-0001-2956-8228)
- Qianrong Hu (ORCID: https://orcid.org/0000-0002-1284-8020)
- Zixu Gao (ORCID: https://orcid.org/0000-0002-5605-3748)
- Jianying Gu (ORCID: https://orcid.org/0000-0002-7870-103X)
- Lu Wang (ORCID: https://orcid.org/0000-0003-4373-7769)
- Yanwen Yang (ORCID: https://orcid.org/0009-0004-3219-8864)
- Yu Zhu (ORCID: https://orcid.org/0000-0002-8369-0208)
- Chenlu Wei
- Tianyi Zhang
Institutions
- Nanchang University (CN)
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Cancer Research
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1158/0008-5472.can-24-0158
- Citations
- 8
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 2.28